Answer
Filgotinib maleate (Jyseleca) is indicated for adults with moderately to severely active ulcerative colitis who have had an inadequate response to, lost response to, or were intolerant to either conventional therapy or a biologic agent.
Sources for this answer
- Jyseleca 100 mg film-coated tabletsAlfasigma UK Limited (formerly Galapagos Biotech Limited) · emc · SmPC §4.1 Therapeutic Indications · Version 20Document updated
Sources checked